Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 151–200 of 2,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02194387	Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members	active not recruiting	N/A	337	M.D. Anderson Cancer CenterOTHER	1	Sep 16, 2026	clinicaltrials
NCT02629809	Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia	active not recruiting	Phase 2	81	M.D. Anderson Cancer CenterOTHER	1	Sep 16, 2026